Cargando…

ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens

The routine availability of high-depth virus sequence data would allow the sensitive detection of resistance-associated variants that can jeopardize HIV or hepatitis C virus (HCV) treatment. We introduce ve-SEQ, a high-throughput method for sequence-specific enrichment and characterization of whole-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonsall, David, Ansari, M. Azim, Ip, Camilla, Trebes, Amy, Brown, Anthony, Klenerman, Paul, Buck, David, Piazza, Paolo, Barnes, Eleanor, Bowden, Rory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821293/ https://www.ncbi.nlm.nih.gov/pubmed/27092241 http://dx.doi.org/10.12688/f1000research.7111.1

Ejemplares similares

Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
por: Smith, David, et al.
Publicado: (2018)

Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR
por: Bonsall, David, et al.
Publicado: (2016)

Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing
por: Iles, James C., et al.
Publicado: (2015)

A Modified RNA-Seq Approach for Whole Genome Sequencing of RNA Viruses from Faecal and Blood Samples
por: Batty, Elizabeth M., et al.
Publicado: (2013)

Genome-to-genome analysis highlights the impact of the human innate and adaptive immune systems on the hepatitis C virus
por: Ansari, M. Azim, et al.
Publicado: (2017)

Defining the key intrahepatic gene networks in HCV infection driven by sex
por: Marchi, Emanuele, et al.
Publicado: (2023)

Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes
por: Thomson, Emma, et al.
Publicado: (2016)

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
por: Ansari, M Azim, et al.
Publicado: (2019)

Ever closer to a prophylactic vaccine for HCV
por: Swadling, Leo, et al.
Publicado: (2013)

Standardized collection of MNase-seq experiments enables unbiased dataset comparisons
por: Rizzo, Jason M, et al.
Publicado: (2012)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
por: Swadling, Leo, et al.
Publicado: (2016)

Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials
por: Bowden, Jack, et al.
Publicado: (2014)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway
por: Manso, Carmen F., et al.
Publicado: (2020)

RNASEQR—a streamlined and accurate RNA-seq sequence analysis program
por: Chen, Leslie Y., et al.
Publicado: (2012)

Interferon lambda 4 variant rs12979860 is not associated with RAV NS5A Y93H in hepatitis C virus genotype 3a
por: Pedergnana, Vincent, et al.
Publicado: (2016)

Unbiased estimation for response adaptive clinical trials
por: Bowden, Jack, et al.
Publicado: (2015)

Direct-seq: programmed gRNA scaffold for streamlined scRNA-seq in CRISPR screen
por: Song, Qingkai, et al.
Publicado: (2020)

Using host genetics to infer the global spread and evolutionary history of HCV subtype 3a
por: Lin, Shang-Kuan, et al.
Publicado: (2021)

Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
por: Bonsall, David, et al.
Publicado: (2018)

Evolutionary dynamics of Enterococcus faecium reveals complex genomic relationships between isolates with independent emergence of vancomycin resistance
por: van Hal, Sebastiaan J., et al.
Publicado: (2016)

Global and unbiased detection of splice junctions from RNA-seq data
por: Ameur, Adam, et al.
Publicado: (2010)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
por: von Delft, Annette, et al.
Publicado: (2018)

GeneTonic: an R/Bioconductor package for streamlining the interpretation of RNA-seq data
por: Marini, Federico, et al.
Publicado: (2021)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
por: Murray, Sam M., et al.
Publicado: (2022)

DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug Discovery
por: Li, Jingyao, et al.
Publicado: (2022)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Streamlined and Abundant Bacterioplankton Thrive in Functional Cohorts
por: Mondav, Rhiannon, et al.
Publicado: (2020)

Unbiased estimation of odds ratios: combining genomewide association scans with replication studies
por: Bowden, Jack, et al.
Publicado: (2009)

ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis
por: Suryatenggara, Jeremiah, et al.
Publicado: (2021)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy
por: Humphreys, Isla S, et al.
Publicado: (2012)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
por: Campbell, Cori, et al.
Publicado: (2021)

They've said it, they've done it
por: Association
Publicado: (2007)

American streamline
por: Hartley, Bernard
Publicado: (1983)

Streamlining in 2008
por: Einspahr, Howard, et al.
Publicado: (2008)

Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis‐driven selection rules
por: Robertson, David S., et al.
Publicado: (2016)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

Unbiased chromatin accessibility profiling by RED-seq uncovers unique features of nucleosome variants in vivo
por: Chen, Poshen B, et al.
Publicado: (2014)

TRACE-seq: A transgenic system for unbiased and non-invasive transcriptome profiling of living cells
por: Cherbonneau, François, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umi2qvuf2lki3qonghj0dc6b1s